Teva Pharmaceutical Industries Limited (TEVA) Comparison with companies in other sectors?

Teva Pharmaceutical Industries Limited has a share price of 1.15B. You can analyze Teva Pharmaceutical Industries Limited (TEVA) competitors across different market sectors through stock heatmaps.

What are TEVA's NET and operating margins?

Teva Pharmaceutical Industries Limited (TEVA) operating margin is around 0.08, and net profit margin is approximately -0.08 as of the latest reports.

In what way does TEVA's earnings per share (EPS) trend reflect its financial momentum?

Teva Pharmaceutical Industries Limited (TEVA) EPS is -1.15 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Teva Pharmaceutical Industries Limited is -14.42, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Teva Pharmaceutical Industries Limited?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Teva Pharmaceutical Industries Limited like P/E which is -14.63, P/B which is 3.001, and PEG which is -0.68. Compare them with sector averages to evaluate if the stock is priced fairly.

Teva Pharmaceutical Industries Limited

TEVA•NYSE

Healthcare

Drug Manufacturers - Specialty & Generic

$16.58

$0.29(1.78%)

Fundamental Analysis of Teva Pharmaceutical Industries Limited (TEVA)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$-1.15

P/E Ratio

-14.42

ROE

-0.21%

Net Margin

-0.08%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$19.02B

Shares OutstandingTotal number of shares issued

$1.15B

Book Value/ShareNet worth per share

$5.51

Revenue/ShareAnnual revenue per share

$14.60

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$-1.15

Net MarginNet income as percentage of revenue

-7.73%

Operating MarginOperating income as percentage of revenue

7.54%

ROEReturn on shareholders' equity

-21.36%

ROAReturn on total assets

-3.35%

ROCEReturn on capital employed

4.60%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$0.95

Cash/ShareCash and equivalents per share

$1.49

FCF YieldFree cash flow as percentage of market cap

5.69%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for TEVAFinancial Ratios Analysis details for TEVA are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for TEVASector Benchmarking details for TEVA are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Teva Pharmaceutical Industries Limited Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Teva Pharmaceutical Industries Limited. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Teva Pharmaceutical Industries Limited's unique business strengths and challenges.

Key Financial Metrics for Teva Pharmaceutical Industries Limited

For Teva Pharmaceutical Industries Limited, essential financial indicators include EPS -1.15, PE -14.42, and ROE -0.21. These key ratios reveal insights into Teva Pharmaceutical Industries Limited's profitability, valuation, and operational health. Understanding these metrics enables you to compare Teva Pharmaceutical Industries Limited with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Teva Pharmaceutical Industries Limited

Metrics like Net Margin -7.73% and ROA -3.35% shed light on how well Teva Pharmaceutical Industries Limited is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Teva Pharmaceutical Industries Limited can sustain its operations and continue growing in the future.

Valuation and Market Position of Teva Pharmaceutical Industries Limited

Using ratios such as P/B Ratio 3.001 and PEG Ratio -0.68, investors can assess whether Teva Pharmaceutical Industries Limited is appropriately valued based on its financials and growth potential. These figures, combined with Teva Pharmaceutical Industries Limited's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Teva Pharmaceutical Industries Limited

Financial health indicators, such as Debt/Equity Ratio 2.71 and Cash Flow $0.95, provide a snapshot of Teva Pharmaceutical Industries Limited's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Teva Pharmaceutical Industries Limited, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Teva Pharmaceutical Industries Limited

Investing in Teva Pharmaceutical Industries Limited based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Teva Pharmaceutical Industries Limited focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;